ArticleFrontiers in immunology2026
Case Report: Novel AK2 variant causing reticular dysgenesis with hemophagocytic lymphohistiocytosis-like syndrome and invasive aspergillosis.
Article in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Reticular dysgenesis (RD) is the most severe form of severe combined immunodeficiency, caused by biallelic AK2 mutations. The association between RD and hemophagocytic lymphohistiocytosis (HLH) remains poorly characterized, with only one prior case reported. Case presentation: A female neonate born to consanguineous parents presented on day 5 of life with fever and profound pancytopenia. Whole-exome sequencing identified a novel homozygous AK2 missense variant (c.79G>C; p.Gly27Arg). The clinical course was complicated by G-CSF-refractory neutropenia, recurrent sepsis, fulminant Aspergillus flavus sinusitis with craniofacial destruction, and HLH-like syndrome (hyperferritinemia 2,258 ng/mL, elevated sCD25 8,450 U/mL). Despite an available HLA-matched sibling donor, hematopoietic stem cell transplantation was precluded by active infection. The patient died at 5 months of age. Conclusion: This is the first report of neonatal RD with concurrent HLH-like syndrome and invasive fungal infection. The novel p.Gly27Arg variant expands the AK2 mutation spectrum. These findings suggest immune dysregulation in RD extends beyond immunodeficiency to include inflammatory dysregulation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.